What is new in European Society of Cardiology ST elevation myocardial infarction guideline?

What is new in European Society of Cardiology ST elevation myocardial infarction guideline?

Gerekli değil

Bibliographic Details
Main Author:	Aylin Yıldırır
Format:	Article
Language:	English
Published:	KARE Publishing 2013-06-01
Series:	Türk Kardiyoloji Derneği Arşivi
Subjects:	acute coronary syndrome anticoagulants; fibrinolytic agents; drug administration schedule; drug interactions; hemorrhage/ blood; myocardial infarction/classification; prasugrel; ticagrelor.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-23434

Similar Items

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

What is new in 2017 European Society of Cardiology ST Elevation Myocardial Infarction guideline?
by: Aylin Yıldırır
Published: (2017-10-01)

Use of antiplatelet agents in patients after myocardial infarction followed up in Moscow outpatient clinics. Results of a non-interventional prospective study
by: A. I. Sapina, et al.
Published: (2024-04-01)

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
by: Sukhdeep S. Basra, et al.
Published: (2018-06-01)

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial
by: Shqipdona Lahu, et al.
Published: (2022-12-01)

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
by: Vojko Kanic, et al.
Published: (2024-01-01)

The use of combination of fibrinolytic therapy and abciximab in the treatment of the acute myocardial infarction with ST elevation
by: Gligić Branko, et al.
Published: (2002-01-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease
by: İbrahim Yıldız, et al.
Published: (2014-07-01)

Comparative effectiveness and safety of prasugrel and ticagrelor in patients of acute coronary syndrome undergoing percutaneous transluminal coronary angioplasty: A propensity score-matched analysis
by: Avik Ray, et al.
Published: (2024-03-01)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
by: Mohammed Essa, et al.
Published: (2023-04-01)

Exploring the morphine-platelet activity association in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Menikae K. Heenkenda, et al.
Published: (2024-12-01)

Does thrombolytic therapy harm or help in ST elevation myocardial infarction (STEMI) caused by the spontaneous coronary dissection?
by: Jović Zoran, et al.
Published: (2015-01-01)

Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
by: Matteo Vercellino, et al.
Published: (2017-04-01)

Prominent features of management strategies in acute coronary syndromes with the new oral antiplatelet agents
by: Rasim Enar
Published: (2013-04-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
by: Georges Jourdi, et al.
Published: (2022-04-01)

Platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor in comparison to clopidogrel: a retrospective pharmacodynamic analysis
by: Gerhard Selhorst, et al.
Published: (2019-04-01)

Efficacy and safety of cangrelor as compared to ticagrelor in patients with ST-elevated myocardial infarction (STEMI): a systematic review and meta-analysis
by: Subhro Chakraborty, et al.
Published: (2024-04-01)

Emerging therapies for acute coronary syndromes
by: Scott M Lilly, et al.
Published: (2011-10-01)

Comparison of ESC and ACCF/AHA Guidelines for Oral Antiplatelet Treatment in the Management of Patients with Acute Coronary Syndrome
by: Ayhan Sarıtaş, et al.
Published: (2016-09-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Konstantinova, et al.
Published: (2016-01-01)

Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial
by: Dorian Garin, et al.
Published: (2024-04-01)

Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?
by: O. V. Averkov, et al.
Published: (2018-09-01)

PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
by: P. V. Dolotovskaya, et al.
Published: (2015-09-01)

INDIVIDUAL APPROACH TO PATIENTS WITH INDICATION FOR ANTIPLATELET THERAPY. WHAT TO RELY ON IN CHOOSING THE THERAPY?
by: N. V. LOMAKIN, et al.
Published: (2017-12-01)

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
by: Salman Nikfarjam, et al.
Published: (2023-01-01)

Comparison of Short Term In-Hospital Outcomes in patients presenting with ST-Elevation Myocardial Infarction Versus Non-ST-Elevation Myocardial Infarction
by: Masood Khan, et al.
Published: (2023-12-01)

Sex-based outcomes on unguided de-escalation from ticagrelor to clopidogrel in stabilized patients with acute myocardial infarction undergoing percutaneous coronary intervention: a post-hoc analysis of the TALOS-AMI
by: Eun-Seok Shin, et al.
Published: (2024-03-01)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023-12-01)

Significance of C-Reactive Protein in Patients with ST-Elevation Myocardial Infarction Over Non-ST-Elevation Myocardial Infarction
by: Shahzadi Anum, et al.
Published: (2023-01-01)

High platelet reactivity is a predictor of left ventricular remodelling in patients with acute myocardial infarction
by: Masahiro Tsuji, et al.
Published: (2022-10-01)

Relationship of ST-segment elevation myocardial infarction with weather and season
by: Okkes Zortuk, et al.
Published: (2024-04-01)

What is new in 2015 ESC nonST Elevation Acute Coronary Syndrome Guideline?
by: Aylin Yıldırır
Published: (2016-02-01)

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
by: Xiao-Fan Yu, et al.
Published: (2022-10-01)

Management of ST-segment elevation myocardial infarction in comparison to European society of cardiology guidelines in Alexandria University Hospitals, Egypt
by: Amr Kamal, et al.
Published: (2023-01-01)

A Case of Subarachnoid Hemorrhage With Persistent Shock and Transient ST Elevation Simulating Acute Myocardial Infarction
by: Hsiang-Chun Lee, et al.
Published: (2004-09-01)

The results of the treatment of right ventricle myocardial infarction
by: Rafajlovski Saša I., et al.
Published: (2005-01-01)